comparemela.com

Latest Breaking News On - Contactcorporate communications - Page 1 : comparemela.com

ITM and Grand Pharma Enter into a Commercialization Agreement for Targeted Radiopharmaceuticals in the Greater China Area

Press release content from Business Wire. The AP news staff was not involved in its creation.

Hong kongValeria fisherBen orzelekSteffen schusterJulia hofmann susanne karlssonFrank zhouContactcorporate communicationsGroup limitedCorporate communicationsTrophic communicationsMedia requeststrophic communicationsTechnologies munichGrand pharmaceutical group limitedChief executive officerGreater chinaTargeted radionuclide therapy

ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therapy to Address Solid Tumors

GARCHING, Germany & MUNICH & HALLE, Germany (BUSINESS WIRE) Dec 2, 2021

Valeria fisherBen orzelekSteffen schusterPriyanka sahasrabudheJulia hofmann susanne karlssonHenning afflerbachContactcorporate communicationsTrophic communicationsBusiness developmentTechnologies munichNavigo proteins gmbhPrecision targetingTargeted radionuclide therapiesTargeted radionuclide therapyRadionuclide therapyNavigo proteins

ITM Isotope Technologies Munich SE: ITM and Navigo Proteins Announce Research Collaboration to Develop FAP-targeting Radionuclide Therapy to Address Solid Tumors

Companies will work toward accessing a novel strategy for breaking the tumor microenvironment by combining ITM's high-quality radioisotopes with Navigo's precise target-specific affinity ligands against

Valeria fisherKostenloser wertpapierhandelBen orzelekPriyanka sahasrabudheSteffen schusterJulia hofmann susanne karlssonHenning afflerbachContactcorporate communicationsTrophic communicationsBusiness developmentTechnologies munichNavigo proteins gmbhPrecision targetingTargeted radionuclide therapiesTargeted radionuclide therapyRadionuclide therapy

vimarsana © 2020. All Rights Reserved.